Ticker
ACR
Analysis
Acrux Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to ACR.
Acrux Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to ACR.
ACR
Stock
$5.5M
Health Technology
Pharmaceuticals: Major
AUD
Acrux Limited may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Update - Licensing Lenzetto for Australia for AUD5.4m
Acrux licenses Lenzetto for Australian market for AUD5.4m
Capital Gains Tax exemptions remain in place for Acrux
Acrux raises $1.6 million via Share Placement
Acrux is a successful Australian pharmaceutical company that develops innovative drugs for the global market. It recently announced its new strategy to enter the final, phase II...
Review valuation context for Acrux Limited.
Review future growth context for Acrux Limited.
Review past performance context for Acrux Limited.
Review financial health context for Acrux Limited.
Review dividend context for Acrux Limited.
Review management context for Acrux Limited.
Review ownership context for Acrux Limited.
Review other information context for Acrux Limited.
Review community context for Acrux Limited.